Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04906096
Title Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lakshmi Nayak
Indications

relapsed/refractory diffuse large B-cell lymphoma

central nervous system lymphoma

Therapies

GDC-0084

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital Not yet recruiting Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field